Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00413179 · ClinicalTrials.gov registry record · Phase 3
The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women
A Phase 3 study, sponsored by 59th Medical Wing.
- Completed
- Registry status
- Phase 3
- Development phase
- 56
- Enrollment target
NCT00413179 is a Phase 3 study that has completed, run by 59th Medical Wing. The registered enrollment target is 56 participants.
The verdict
NCT00413179, a Phase 3 study, has completed, sponsored by 59th Medical Wing.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of our study was to conduct a placebo controlled, double-blind randomized trial in chronic oligoovulatory or anovulatory , hyperandrogenic, infertility patients comparing the effects of adjuvant metformin plus clomiphene citrate to clomiphene citrate plus placebo on pregnancy rates and ovulation rates. We hypothesized that combining metformin with clomiphene citrate would result in higher ovulation and pregnancy rates in hyperandrogenic women who have chronic oligoovulation or anovulation as the sole etiology for their infertility and who have unknown responsiveness to clomiphene citrate.
Interventions
- DRUG Placebo
- DRUG Metformin
- DRUG Clomiphene citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 1997-12 |
| Est. Completion | 2003-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00413179
The ClinicalTrials.gov registry entry for NCT00413179 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 59th Medical Wing, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00413179 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00413179 about?
NCT00413179 is a clinical study titled "The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory Women". The purpose of our study was to conduct a placebo controlled, double-blind randomized trial in chronic oligoovulatory or anovulatory , hyperandrogenic, infertility patients comparing the effects of adjuvant metformin plus clomiphene citrate to clomiphene citrate plus placebo on pregnancy rates and o...
What is the current status of trial NCT00413179?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 56 participants. The study started on 1997-12. Estimated completion is 2003-04.
What interventions are being tested in trial NCT00413179?
The interventions under investigation include: Placebo (DRUG), Metformin (DRUG), Clomiphene citrate (DRUG).
Who is sponsoring clinical trial NCT00413179?
This trial is sponsored by 59th Medical Wing, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.